Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement
Background: Diagnosis of multiple sclerosis (MS) is established on criteria according to clinical and radiological manifestation. Cerebrospinal fluid (CSF) analysis is an important part of differential diagnosis of MS and other inflammatory processes in the central nervous system (CNS). Methods: In...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-02-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/11/2/425 |
| _version_ | 1797622241942306816 |
|---|---|
| author | Mariola Świderek-Matysiak Magdalena Oset Małgorzata Domowicz Grażyna Galazka Magdalena Namiecińska Mariusz Stasiołek |
| author_facet | Mariola Świderek-Matysiak Magdalena Oset Małgorzata Domowicz Grażyna Galazka Magdalena Namiecińska Mariusz Stasiołek |
| author_sort | Mariola Świderek-Matysiak |
| collection | DOAJ |
| description | Background: Diagnosis of multiple sclerosis (MS) is established on criteria according to clinical and radiological manifestation. Cerebrospinal fluid (CSF) analysis is an important part of differential diagnosis of MS and other inflammatory processes in the central nervous system (CNS). Methods: In total, 242 CSF samples were collected from patients undergoing differential MS diagnosis because of the presence of T2-hyperintensive lesions on brain MRI. The non-MS patients were subdivided into systemic inflammatory diseases with CNS involvement (SID) or cerebrovascular diseases (CVD) or other non-inflammatory diseases (NID). All samples were analyzed for the presence of oligoclonal bands and ELISA was performed for detection of: INF gamma, IL-6, neurofilaments light chain (NF-L), GFAP, CHI3L1, CXCL13, and osteopontin. Results: The level of IL-6 (<i>p</i> = 0.024), osteopontin (<i>p</i> = 0.0002), and NF-L (<i>p</i> = 0.002) was significantly different among groups. IL-6 (<i>p</i> = 0.0350) and NF-L (<i>p</i> = 0.0015) level was significantly higher in SID compared to NID patients. A significantly higher level of osteopontin (<i>p</i> = 0.00026) and NF-L (<i>p</i> = 0.002) in MS compared to NID population was noted. ROC analysis found weak diagnostic power for osteopontin and NFL-L. Conclusions: The classical and non-standard markers of inflammatory process and neurodegeneration do not allow for sufficient differentiation between MS and non-MS inflammatory CNS disorders. Weak diagnostic power observed for the osteopontin and NF-L needs to be further investigated. |
| first_indexed | 2024-03-11T09:07:20Z |
| format | Article |
| id | doaj.art-c805f1becc2d45f5a28047e9c469d2e5 |
| institution | Directory Open Access Journal |
| issn | 2227-9059 |
| language | English |
| last_indexed | 2024-03-11T09:07:20Z |
| publishDate | 2023-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomedicines |
| spelling | doaj.art-c805f1becc2d45f5a28047e9c469d2e52023-11-16T19:18:04ZengMDPI AGBiomedicines2227-90592023-02-0111242510.3390/biomedicines11020425Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System InvolvementMariola Świderek-Matysiak0Magdalena Oset1Małgorzata Domowicz2Grażyna Galazka3Magdalena Namiecińska4Mariusz Stasiołek5Department of Neurology, Medical University of Lodz, Kościuszki Street 4, 90-419 Lodz, PolandDepartment of Neurology, Medical University of Lodz, Kościuszki Street 4, 90-419 Lodz, PolandDepartment of Neurology, Medical University of Lodz, Kościuszki Street 4, 90-419 Lodz, PolandDepartment of Neurology, Medical University of Lodz, Kościuszki Street 4, 90-419 Lodz, PolandDepartment of Neurology, Medical University of Lodz, Kościuszki Street 4, 90-419 Lodz, PolandDepartment of Neurology, Medical University of Lodz, Kościuszki Street 4, 90-419 Lodz, PolandBackground: Diagnosis of multiple sclerosis (MS) is established on criteria according to clinical and radiological manifestation. Cerebrospinal fluid (CSF) analysis is an important part of differential diagnosis of MS and other inflammatory processes in the central nervous system (CNS). Methods: In total, 242 CSF samples were collected from patients undergoing differential MS diagnosis because of the presence of T2-hyperintensive lesions on brain MRI. The non-MS patients were subdivided into systemic inflammatory diseases with CNS involvement (SID) or cerebrovascular diseases (CVD) or other non-inflammatory diseases (NID). All samples were analyzed for the presence of oligoclonal bands and ELISA was performed for detection of: INF gamma, IL-6, neurofilaments light chain (NF-L), GFAP, CHI3L1, CXCL13, and osteopontin. Results: The level of IL-6 (<i>p</i> = 0.024), osteopontin (<i>p</i> = 0.0002), and NF-L (<i>p</i> = 0.002) was significantly different among groups. IL-6 (<i>p</i> = 0.0350) and NF-L (<i>p</i> = 0.0015) level was significantly higher in SID compared to NID patients. A significantly higher level of osteopontin (<i>p</i> = 0.00026) and NF-L (<i>p</i> = 0.002) in MS compared to NID population was noted. ROC analysis found weak diagnostic power for osteopontin and NFL-L. Conclusions: The classical and non-standard markers of inflammatory process and neurodegeneration do not allow for sufficient differentiation between MS and non-MS inflammatory CNS disorders. Weak diagnostic power observed for the osteopontin and NF-L needs to be further investigated.https://www.mdpi.com/2227-9059/11/2/425multiple sclerosisdifferential diagnosiscerebrospinal fluidoligoclonal bandsneurofilaments light chaininterleukin 6 |
| spellingShingle | Mariola Świderek-Matysiak Magdalena Oset Małgorzata Domowicz Grażyna Galazka Magdalena Namiecińska Mariusz Stasiołek Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement Biomedicines multiple sclerosis differential diagnosis cerebrospinal fluid oligoclonal bands neurofilaments light chain interleukin 6 |
| title | Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement |
| title_full | Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement |
| title_fullStr | Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement |
| title_full_unstemmed | Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement |
| title_short | Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement |
| title_sort | cerebrospinal fluid biomarkers in differential diagnosis of multiple sclerosis and systemic inflammatory diseases with central nervous system involvement |
| topic | multiple sclerosis differential diagnosis cerebrospinal fluid oligoclonal bands neurofilaments light chain interleukin 6 |
| url | https://www.mdpi.com/2227-9059/11/2/425 |
| work_keys_str_mv | AT mariolaswiderekmatysiak cerebrospinalfluidbiomarkersindifferentialdiagnosisofmultiplesclerosisandsystemicinflammatorydiseaseswithcentralnervoussysteminvolvement AT magdalenaoset cerebrospinalfluidbiomarkersindifferentialdiagnosisofmultiplesclerosisandsystemicinflammatorydiseaseswithcentralnervoussysteminvolvement AT małgorzatadomowicz cerebrospinalfluidbiomarkersindifferentialdiagnosisofmultiplesclerosisandsystemicinflammatorydiseaseswithcentralnervoussysteminvolvement AT grazynagalazka cerebrospinalfluidbiomarkersindifferentialdiagnosisofmultiplesclerosisandsystemicinflammatorydiseaseswithcentralnervoussysteminvolvement AT magdalenanamiecinska cerebrospinalfluidbiomarkersindifferentialdiagnosisofmultiplesclerosisandsystemicinflammatorydiseaseswithcentralnervoussysteminvolvement AT mariuszstasiołek cerebrospinalfluidbiomarkersindifferentialdiagnosisofmultiplesclerosisandsystemicinflammatorydiseaseswithcentralnervoussysteminvolvement |